Beijing's SL Pharma and Canada's PnuVax Form Vaccine, Antibody JV
SHANGHAI - Beijing's SL Pharmaceutical announced it will invest CAD $20 million to form a joint venture in Ontario, Canada with Canadian partner PnuVax Incorporated.
SHANGHAI - Beijing's SL Pharmaceutical announced it will invest CAD $20 million to form a joint venture in Ontario, Canada with Canadian partner PnuVax Incorporated.